Benzinga | Aug 3, 2021 04:46PM EDT

Cardlytics Q2 Adj. EPS $(0.39), Inline, Sales $58.90M Miss $62.81M Estimate; Sees Q3 Sales $57M-$66M vs $71M Estimate, Billings $85M-$95M

Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.39) per share which met the analyst consensus estimate. This is a 2.63 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $58.90 million which missed the analyst consensus estimate of $62.81 million by 6.23 percent. This is a 108.70 percent increase over sales of $28.22 million the same period last year.